Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Patent
1994-03-25
1997-11-25
Stanton, Brian R.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
424 91, 424 9321, 4351723, 435325, 435352, 435353, 435366, C12N 506, C12N 516, C12N 1509, A01N 6300
Patent
active
056909268
ABSTRACT:
The claimed invention is directed towards non-murine pluripotential cells that have the ability to be passaged in vitro for at least 20 passages and which differentiate in culture into a variety of tissues. The scope of the claimed cells includes any non-murine ES cells and particular claims are drawn to human pluripotential cells.
REFERENCES:
patent: 5166065 (1992-11-01), Williams et al.
Bradley et al., 1992, "Modifying the mouse: Design and Desire", Biotechnology 10:534-539, Mar. 1992.
McMahon et al., 1990, "The Wnt-1 (int-1) proto-oncogen is required for development of a large region of the mouse brain", Cell 62:1073-1085, Sep. 21, 1990.
H.P.M. Pratt, 1987, "Isolation, culture, and manipulations of preimplantation mouse embryos", in Mammalian Development: A practical Approach, M. Monk, ed., IRL Press, Washington, DC., pp. 13-42.
Lapidot et al., Science 255:1137-1141 (1992).
Anne McLaren, Nature 359:482-483 (1992).
Reynolds & Weiss, Science, 1707-1710(1992).
Snouwaert t al., Science, 257:1083-1088 (1992).
Erwin F. Wagner, The EMBO Journal, 9:3025-3032 (1990).
Stemple and Anderson, Cell 71:973-985 (1992).
Jones et al., Nature 347:188-189 (1990).
Resnick et al., Nature 359:550-551 (1992).
Evans and Kaurman, nNture 292:154-156 (1981).
Martin, PNAS 78:7634-7638 (1981).
Bradley et al., Nature 309:255-256 (1984).
Rathjen, P.D. Genes Dev. 4:2308-2318 (1990).
Rathjen, Cell 62:1105-1114 (1990).
De Felici and McLaren, Exp. Cell Res. 144:417-427 (1983).
Wabik-Sliz and McLaren, Exp. Cell. Res. 154:530-536 (1984).
Donovan et al., Cell 44:831-838 (1986).
Dolci et al., Nature 352:809-811 (1991).
Matsui et al., Nature 353:750-752 (1991).
Stewart and Mintz, Proc. Nat'l. Acad. Sci. U.S.A. 78:6314-6318 (1981).
Mintz et al., Proc. Nat'l. Acad. Sci. U.S.A. 75:2834-2838 (1978).
Noguchi and Stevens, J. Nat'l Cancer Inst. 69:907-913 (1982).
Ginsburg et al., Development 110:521-528 (1990).
Monk et al., Development 99:371-382 (1987).
Godin et al., Nature 352:807-808 (1991).
Matsui et al., Cell 70:841-847 (1992).
Notarianni et al., Journals of Reproduction & Fertlity Supplement 41:51-56 (1990).
Smith et al., Nature 336:688-690 (Dec. 15, 1988).
Mummery et al., Cell Differentiation and Development 30:195-206 (Jun. 1, 1990).
Piedrahita et al., Theriogenology 29:286 (Jan. 1988).
Handyside et al., Roux's Arch. Dev. Biol. 196:185-190 (1987).
Flake et al., Science 233:776-778 (Aug. 15, 1986).
Ware et al., Biology of Reproduction Supp. 38:129 (1988).
Robertson et al. Nature 323:445-448 (1986).
Labosky et al., 1994 Germline development, Wiley, Chichester (Ciba Foundation Symposium 182) pp. 1557-178.
Patent application abstract, U.S. Serial No. 07/958,009, Apr. 1, 1993.
Mar. 25, 1994 letter from Judith Plesset, Ph.D., Technology Licensing Specialist, Office of Technology Transfer, Department of Health and Human Services, National Institutes of Health, reporting abandonment of U.S. Serial No. 07/958,009.
Stanton Brian R.
Vanderbilt University
LandOfFree
Pluripotential embryonic cells and methods of making same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pluripotential embryonic cells and methods of making same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pluripotential embryonic cells and methods of making same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2104395